课题基金 / 基金详情

项目摘要

项目成果

HELEN E HESLOP的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goals of the cliniclal research core are to provide all projects with centralized clinical trial support and provide an infrastructure of personnel and services that will adequately support such research. Core services will be provided in regulatory affairs, study coordination, quality assurance and control and data safety monitoring. The Regulatory Affairs component collaborates with investigators to develop and submit all required regulatory documents, including submissions to the IRB, IBC, FDA, and NIH/ORDA and annual reports. This core has extensive experience with IND submission and currently supports over 25 IND studies. The Quality Control (QC) program will ensure that standard operating procedures for protocol development, conduct of clinical trials, data collection and management of clinical trials are accurately defined and being followed. The QA program will undertake audits after the first patient is enrolled on a study and then randomly to ensure that the studies are being conducted according to Good Clinical Practices. The core will also co-ordinate data monitoring by the Data Review Committee which is responsible for reviewing and evaluating toxicity and any other study-relevant safety-related data for clinical research studies in this SPORE. The core will also arrange internal group meetings of the investigators, attending physicians, statisticians, research nurse, data manager, and appropriate nurse managers to ensure that the clinical studies are conducted both safely and efficiently. It will also provide research nurse support to faciliate conduct of clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT
  • 批准号:
    9069027
  • 项目类别:
  • 资助金额:
    $16.02万
  • 财政年份:
    2011
  • 负责人:
    HELEN E HESLOP
  • 依托单位:
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT
  • 批准号:
    8479213
  • 项目类别:
  • 资助金额:
    $16.02万
  • 财政年份:
    2011
  • 负责人:
    HELEN E HESLOP
  • 依托单位:
MOST CLOSELY HLA MATCHED ALLOGENEIC VIRUS SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL)
  • 批准号:
    8356704
  • 项目类别:
  • 资助金额:
    $0.2万
  • 财政年份:
    2010
  • 负责人:
    HELEN E HESLOP
  • 依托单位:
CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI
  • 批准号:
    8356760
  • 项目类别:
  • 资助金额:
    $0.12万
  • 财政年份:
    2010
  • 负责人:
    HELEN E HESLOP
  • 依托单位:
海外基金